NasdaqCM:RZLTBiotechs
Vivani Stock Puts These Obesity And Diabetes Treatment Stocks On The Radar
The race to reshape obesity and diabetes treatment is moving beyond weekly injections, and Vivani Medical’s long-acting GLP-1 implant has pushed that story into the spotlight. For investors, the question is how this kind of delivery shift might affect companies tied to GLP-1 drugs, devices, and support therapies. This article looks at 3 stocks from our Obesity and Diabetes Treatment Innovation screener that appear positively exposed to the same forces driving interest in Vivani’s semaglutide...